Actilyse 50mg Injection
Actilyse 50mg Injection belongs to a group of drugs called thrombolytics and they dissolve blood clots quickly. It helps restart blood flow to the heart and also helps prevent damage to the heart muscle. In simple words we can say that this medicine helps in dissolving blood clots.
This medication is available in an injectable dosage form to be given directly intravenously by a health care professionals. A common side effect of this medication is bleeding.
It is a prescription medication used to treat:
Acute myocardial infarction (heart attack)
Acute ischemic stroke (loss of blood flow to the brain)
Pulmonary embolism (blood clot that has travelled to the lungs)
Do not take alteplase if you:
are allergic to alteplase or any of its ingredients
have an active bleed
have a history of a brain injury
have had recent major surgery or trauma especially in the head
severely uncontrolled high blood pressure
have or have had any problems managing bleeding conditions in the past
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.
Use
The medication can treat the below provided problems:
Heart Attack
Stroke
Side Effects
A patient can suffer from the following side effects:
Nausea
Vomiting
Decreased Blood Pressure
Injection Site Bleeding
Dosage
Are there any overdose instructions?
Seek emergency medical treatment or contact the doctor in case of an overdose.
Are there any missed dose instructions?
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Work
This medication belongs to one of the kinds of blood thinner, primarily used to treat myocardial infarctions and other clotting disorders. The fibrin rich clots are bound by the drug, through the Kringle 2 and fibronectin domain.
Reviews
There are no reviews yet.